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Abstract 
 
PURPOSE.  Knowledge of genetic factors predisposing to age-related cataract is very 
limited. We aimed to identify DNA sequences that either lead to or predispose to cataract.  
METHODS.  We sequenced the candidate gene SLC16A12, which encodes a solute carrier of 
the monocarboxylate transporter family, in 484 cataract patients (134 with juvenile cataract, 
350 with age-related cataract) and 190 control individuals.   
RESULTS.  One patient with age-related cataract showed a novel heterozygous mutation (c.-
17A>G) in the 5’untranslated region (5’UTR). This mutation is in cis with the minor G allele 
of the single nucleotide polymorphism (SNP) rs3740030 (c.-42T/G), also within the 5’UTR. 
Using a luciferase reporter assay system, a construct with the patient’s haplotype caused a 
significant upregulation of luciferase activity. In comparison, the SNP G-allele alone 
promoted less activity but that amount was still significantly higher than that of the common 
T-allele. Analysis of SLC16A12 transcripts in surrogate tissue demonstrated striking allele-
specific differences causing 5’UTR heterogeneity with respect to sequence and quantity. 
These differences in gene expression were mirrored in an allele-specific predisposition to 
age-related cataract, as determined in a Swiss population (odds ratio of approximately 2.2 
with confidence intervals from 1.23 to 4.3).  
CONCLUSIONS. The monocarboxylate transporter SLC16A12 may contribute to age-
related cataract.  Sequences within the 5’UTR modulate translational efficiency with 
pathogenic consequences.  
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Introduction 
 
Cataract is the clouding of the eye’s lens that impairs normal vision. It is estimated that 
cataract accounts for 17 million cases of blindness worldwide, with approximately half of all 
cases originating from Asia and Africa.1, 2 Different criteria can be used to classify the 
various forms of cataracts: age of onset, morphological features or mode of inheritance. 
Based on the age of onset, one distinguishes between childhood (congenital and juvenile) and 
age-related cataract (ARC) but this criterion does not necessarily indicate the etiology.3 
Genetic predisposition plays a crucial role for childhood cataract of the individual.1, 2 
Congenital and juvenile forms of cataract show wide heterogeneity with respect to the 
genetic and phenotypic aspects.4 A number of mutations in about 20 genes have been 
described to cause childhood cataract.3, 5-7    
Approximately 80% of all cataracts are age-related and idiopathic. Depending on the location 
of the opacity within the lens, the age-related cataracts are termed cortical, nuclear or 
subcapsular. There are also cases of mixed cataract forms that feature more than one 
morphological sign. In general, maintenance of an intact, transparent lens requires balanced 
homeostasis of metabolic components.8 ARC is considered a multi-factorial disease, where 
environmental components as well as genetic predisposition contribute to the development of 
the pathological condition. Interactions between these factors are likely and knowledge of the 
cause of age-related cataracts could provide crucial information for prevention or potential 
therapy of the disease. Among the environmental risk factors are smoking, exposure to 
ultraviolet B (UVB) radiation and alcohol.9 In addition, physiological conditions as age, sex, 
diabetes, high body mass index, persistent intraocular inflammation, prolonged corticosteroid 
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administration and oxidative damage seem to promote the development of ARC.9  In light of 
this complexity, knowledge of genetic risk factors is still scarce. Variants of detoxifying 
enzymes arylamine N-acetyltransferase 2 and glutathione S-transferase (GST) were found to 
associated with age-related cataract.10-12 Furthermore, two sequence variants in the vicinity of 
the 3’ end of the gene for Eph-receptor tyrosine kinase type A2 (EPHA2) were shown to 
associate with both, childhood and age-related forms of cataract.13  Recently a mutation in 
the gene encoding αA-Crystallin was reported to be associated with ARC, due to loss of 
chaperone-like activity.14  SNP based allele frequencies and consequently association with a 
disease phenotype vary often among different ethnic groups, which is exemplified by a 
sequence variant in the gene encoding galactokinase, an enzyme involved in galactose 
metabolism 15, 16 as well as for GST .10, 11, 17  Similarly, heat shock transcription factor 4 may 
be involved in age-related cataract in an Asian population. 18    
To the list of genes involved in childhood cataract 19 we recently added the gene SLC16A12, 
encoding a monocarboxylate transporter.6  Although the substrate of this transporter is not 
yet known, its importance for establishment or maintenance of homeostasis was suggested 
since a premature termination codon in SLC16A12 leads to juvenile cataract and renal 
glucosuria.6 Based on this proposed function of the transporter, we speculated that 
insufficient activity could interfere with maintenance of homeostatic conditions within the 
lens and lead to age-related cataract. Now we report the effects of two sequence alterations in 
the 5’untranslated leader region (5’UTR) of SLC16A12 on age-related cataract. The 
importance of 5’UTR sequences for translational regulation has been demonstrated in several 
other genes.20-23 About 10% of all coding genes are regulated at the mRNA level and hence 
influence translational efficiency. Disturbance of the regulation of the translational 
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machinery leads to perturbed cellular metabolism and may tilt the physiological balance from 
healthy to diseased states such as breast cancer, Alzheimer’s disease, bipolar affective 
disorder, fragile X-syndrome or others.20, 22  Our work focuses on sequence alterations within 
the 5’UTR of SLC16A12 and offers an explanation on the development of age-related 
cataract.  
 
Material and Methods 
Patients 
Patients with childhood and age-related cataract, which included cortical, nuclear, posterior 
sub-capsular and mixed types of cataract were collected in Switzerland. Individuals from 
Switzerland, representing the general population, served as control. Information on 
hypertension, diabetis mellitus, smoking behaviour, alcohol consumption or exposure to 
UVB radiation was not available.  Patients gave written consent to participation in scientific 
research.  All experiments involving human subjects were conducted according to the 
principles expressed in the Declaration of Helsinki.   
DNA analysis 
DNA was prepared either by the method of precipitation using the Gentra Kit (Qiagen, 
Hilden, Germany) or by magnetic beads technology from Chemagen (Aachen, Germany).  
For PCR, approximately 50 ng template DNA and primers (Table 1) were cycled 35 times 
with annealing and extension temperatures of 60 and 72°C, respectively, lasting 1 minute 
each. DNA sequencing was performed using ABI technology (Applied Biosystems, 
Rotkreuz, Switzerland).  
RNA analysis 
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RNA from vascular smooth muscle cell cultures (VSMC) was isolated using the All Prep 
DNA RNA Mini Kit from Qiagen (Qiagen, Hilden, Germany). RNA was evaluated with the 
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Two-step RT-PCR 
required cDNA synthesis using Superscript III (Invitrogen, Basel, Switzerland).  Standard 
RT-PCR conditions were applied using Hotfire Taq Polymerase (Solis Biodyne, Tartu, 
Estonia), 1 minute at 58°C annealing temperature, 1 minute elongation time at 72°C and 39 
cycles. PCR products were analyzed by 1% agarose gel electrophoresis. Quantitative 
sequencing of the SLC16A12 c.-42T>G variant was performed as published.24 Briefly, to 
determine the correction factors, genomic DNA (gDNA) was amplified in duplicates and 
each amplicon was sequenced in eight different reactions. For RNA, one-step RT-PCRs 
(Qiagen, Hilden, Germany) were performed in triplicates and each amplicon was sequenced 
eight times. Potential splice sites were searched for by using the on-line tool ESE-finder 25, 26 
(http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder).  
In silico analysis of 5’ UTR variants on RNA folding 
Putative RNA folding structures were predicted using Mfold with standard settings 
(http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi).27 RNA structures were predicted for 
SLC16A12 (ref. NM_213606) as well as 5’UTR alone.  
Plasmids, Vectors and Cloning 
Exon 3 of  SLC16A12 contains part of the 5’UTR and the initiation ATG followed by 36 
encoded amino acids. A fragment of 118 bp SLC16A12 sequence (5’-
GCCAGGTAGCGTTCTATGCCAACCTTGAATGCCATCAGGAAGTCACTGGACAGC
AAACTCTTCCAAGATCATAACTT[G/T]GGCTGTTGGAGCAACCTGGAAAAG[A/G]
AGAAAAAAGAAAAACC-3’, was cloned in front of the luciferase gene in pGL3 control 
Zuercher et al Page 7 8/17/2010 
vector (Promega, Madison, USA) with HindIII and NcoI restriction enzymes. For this 
purpose, exon 3 was PCR amplified using an upstream primer (Table 2) that contained a 
HindIII restriction at its 5’end and a downstream primer (Table 2). Genomic DNA 
heterozygous for the SNP rs3740030 and genomic DNA from the cataract patient with c.-
42G/T and c. -17A/G served as templates. PCR amplicons and vector pGL3 were digested 
with restriction enzymes HindIII and NcoI and ligated with DNA ligase (Promega, Madison, 
USA). Constructs were verified by DNA sequence analysis.   
Mammalian Cell Culture Experiments 
104 HEK293T cells were seeded per 96-well in 0.5 ml DMEM, 10% FBS, 1% penstrep and 
transfected 24 hours later. A total of 615 ng plasmid DNA (600 ng pFirefly construct and 15 
ng pRenilla construct) dissolved in 2 µl Calcium chloride (c = 2.5 mol/l)  and 10 µl HeBS 
(2x) were used per transfection (20 µl transfection mix/well). Cells were harvested 48 hours 
after transfection, and Luciferase activities were measured by the Promega Dual Glo 
Luciferase reporter assay system using Luminoskan Ascent (ThermoLabsystems, Egelsbach, 
Germany).  
Isolation and cultivation of Vascular Smooth Muscle Cells (VSMC) 
VSMCs were isolated from radial arteries of patients undergoing coronary artery bypass 
grafting as previously described.28 Identification was done by immunofluorescent staining for 
smooth muscle alpha-actin (No. 1148818, Roche Diagnostics, Mannheim, Germany). Cells 
were grown in Dulbecco’s MEM supplemented with 10% fetal calf serum (FCS) and used up 
to passage ten. 
Statistics 
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DNA analysis: For statistical calculation of odds ratio and significance, an open access 
internet portal was used (http://faculty.vassar.edu/lowry/odds2x2.html, June 2009).  
Calculations were based on a p = 0.05 level of significance. 
RNA analysis: For the arithmetic mean of replicates (n=4 for gDNA and n=6 for cDNA), 
upper and lower confidence limits were determined using critical values of paired t-test 
distribution.   
Mammalian cell culture experiments: Averages and confidence intervals (paired T-test) were 
calculated and normalized on T-allele activity. The tissue culture experiments were 
performed twice using three technical replicas per measurement.   
 
 
Results 
 
Identification of mutation in the 5’UTR of SLC16A12 and patient characteristics 
For mutation screening we investigated genomic DNA from 350 patients with age-related 
cataract and 134 patients with childhood cataract. DNA sequences from all exons and 
adjacent intron regions of SLC16A12 were analyzed. A 79 year old female patient with age-
related cataract was found to carry a heterozygous sequence alteration in the 5’UTR (c.-
17A>G) (Fig. 1) but coding and approximately 50 nucleotides flanking intron sequences 
were unchanged. The sequence change was not found in any of the other 483 patients or in 
380 alleles from control individuals. This uniqueness makes the change unlikely a normal 
sequence variant but rather indicates pathogenicity. Hence we will refer to it from now on as 
mutation. The patient was also heterozygous at an annotated SNP rs3740030 (c.-42T/G) that 
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lies just upstream of the mutation. Cloning and sequencing of the patient’s exon 3 showed 
that the mutation and the G-allele are on the same chromosome.  
The female patient was seen by an ophthalmologist for cataract. The lens of her left eye 
showed nuclear and subcapsular opacities plus pseudoexfoliation of the lens capsule and was 
removed at age 75. At the age of 79 years her right eye was also subjected to surgery. The 
right lens showed nuclear brunescent sclerosis with pulverulent anterior and posterior cortical 
opacities plus pseudoexfoliation of the lens capsule. No information about other family 
members was available.   
Quantitative assessment of SLC16A12 transcripts 
Since the minor G-allele and the mutation reside within the 5’UTR of SLC16A12 it is likely 
that these changes affect translational rather than transcriptional efficiency. To assess this 
unlikely possibility we determined the amount of SLC16A12 mRNA by quantitative 
sequencing experiments, a method that requires RNA from heterozygous tissue. It is based 
on comparing allele frequencies of complementary DNA (cDNA) with those of genomic 
DNA (gDNA) from the same sample.24 As no tissue was available from the cataract patient, 
we focused our attention on measuring SNP allele-specific transcripts. Among available 
tissues that were known to express SLC16A12, vascular smooth muscle cells (VSMC) from 
heterozygous donors served as surrogate tissue. RNA was subjected to one-step RT-PCR 
using primers in exons 3 and 5 to including the SNP (Fig. 2A). As expected, contribution of 
the T-allele in genomic DNA was 50% (+/- 3%). No significant difference was measured for 
the T-allele in the cDNA (57% +/- 9%) (Fig. 2B) meaning the two SNP alleles are present at 
comparable amounts. We conclude that not differential transcription but rather regulatory 
mechanisms of translation are affected by the patients sequence alterations.  
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SLC16A12 5’UTR sequences at c.-42 and c.-17 influence translational efficiency  
To investigate whether the SNP and the patient’s c.-17A>G mutation have an effect on 
translation, constructs containing 5’UTR sequences in front of the luciferase gene were tested 
upon transfection of HEK cells and luciferase reporter activity was measured (Fig. 3). This 
method is well feasible to simulate translational activity changes since all constructs contain 
the same promoter, hence making it likely that transcriptional efficiency is the same among 
all constructs (Fig. 3A). Statistically significant differences in luciferase activity were 
observed between all three SLC16A12 constructs (Fig. 3B). The construct that mimics the 
patient’s haplotype yielded highest luciferase activity compared to both normal SNP alleles 
(2.315±0.433 fold higher). Furthermore, the normal SNP alleles yielded significantly 
different luciferase activities such that the minor G allele led to higher levels compared to the 
more common T-allele (1.362±0.07 fold higher). These results demonstrate a significant 
effect of 5’UTR sequences and suggest enhanced potential of SLC16A12 translation.  
 
Effects of 5’UTR on RNA folding by in silico analysis  
One possible mechanism to achieve such regulation is through RNA folding. We simulated 
the influence of the 5’UTR sequence variants on secondary structures using the method 
Mfold 27 that predicts a structure based on free energy minimization. RNA structures of the 
entire SLC16A12 mRNA, (5’UTR, coding sequences (CDS) and 3’UTR) were predicted (Fig. 
4 A, B, C). Differences between the T- and the G-allele of SNP rs3740030 affect some 
branches near the center of the molecule (Fig. 4A, B). The patient’s mutation in combination 
with the SNP G-allele caused a strikingly different RNA structure (Fig. 4C). 5’UTR 
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sequences alone also folded in an allele-specific manner (Fig. 4D, E, F). Taken together, our 
experimental data in combination with the bioinformatic predictions indicate an effect on 
nucleotide specific RNA folding properties.  
  
SNP allele-specific sequence heterogeneity of 5’UTR SLC16A12 transcripts  
The 5’UTR contains exon1, 2 and part of exon3 sequences.  To assess potential splicing 
effects on the generation of the 5’UTR we initially applied the on-line tool ESE finder v3.0.  
Splice factor SC35 was predicted to bind to the region immediately adjacent to the SNP, 
independent of the allele-specific nucleotide (Fig. 5). Interestingly, splice factor SRp40 was 
predicted to bind exclusively to G-allele transcripts and not to the T-allele transcripts. No 
binding sites for any of the ESE-finder specific splice factors were found at the c.-17.   
These observations supported the existence of alternative and allele-specific splicing of 
SLC16A12 transcripts generating 5’UTR heterogeneity. To test these predictions, we 
performed RT-PCR experiments with various primer combinations on cDNA from vascular 
smooth muscle cells from donors, which were either homozygous T/T or heterozygous G/T 
with respect to the SNP rs3740030 (Fig. 6).  
Primer combination III (Exons 3, 4 and 5) yielded amplicons of highly similar intensity (Fig. 
6) confirming our quantitative transcript data that showed no allele-specific effect (Fig.2).  
SNP nucleotide identity, T or G/T, was confirmed by sequencing. Amplification with primer 
combinations I yielded fragments displaying heterogeneity in size, sequence and intensity.  
Surprisingly, in heterozygous samples these were greatly reduced and only two samples 
showing a weakly staining single fragment (Fig.6 B). DNA sequence analysis of sample 5 
(primer combination II) revealed the expected presence of exon 2, 3 and 4 but unexpectedly 
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only the T nucleotide of the SNP. Sample 8 (primer combination I) contained in addition to 
exon 1, 2 and 3 also a short fragment intron1 sequence. At the SNP position only the G 
nucleotide was found. The weak staining of this fragment suggested reduced levels of this 
transcript, which may be the reason for chance amplification. The sequence heterogeneity in 
the homozygous samples resulted from some fragments containing exons1, 2 and 3, others 
had an additional short segment of intron 1, and yet others lacked exon 2. Primer 
combination II amplified fragments containing exon 2, exon3 and exon 4 sequences (DNA 
sequence data not shown). The striking differences between the homozygous and 
heterozygous samples within the 5’UTR region indicated the possibility of an allele-specific 
splicing mechanism that leads to severe reduction of transcripts containing exon1 and 2 in 
heterozygous tissues. 
 
Allele-specificity affects the risk to develop cataract.   
Assessment of the genotype for SNP rs3740030 in 484 cataract patients (350 with ARC and 
134 with childhood cataract), mostly with Caucasian background and ethnically matched 190 
control individuals confirmed an over-representation of the T-allele (Table 2), as had been 
reported for Caucasian populations of European descent (HapMap: T-allele frequency of 
91.6%; ). Furthermore, we noticed over-representation of the G-allele in the patient groups 
compared to controls (juvenile: 6.72%, age-related: 8.71% and controls 4.21%), which was 
statistically significant only for the age-related cataract patient group (p = of 0.00601768; Chi 
square = 7.545). To assess the extent to which the G-allele could increase the risk to develop 
cataracts, odds ratios were calculated.  Individuals with either the G- allele only or the G/T or 
G/G genotype are at increased risk to develop age-related cataract by approximately 2.2 fold 
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(Table 3).  Conversely, the T allele or T/T genotype confers protection against age-related 
cataracts. Since the control population originated from the general Swiss population, we 
cannot exclude the possibility that an individual may develop age-related cataracts. In such 
case we would predict that the odds ratio shifts even further towards a risk association with 
the G-allele.  Odds ratios for the juvenile cataract were statistically not significant (Table 3).   
   
Discussion 
The complex diseases age-related cataract (ARC) is influenced by a multitude of 
environmental and genetic factors.  Knowledge of the identity of the genetic contributions is 
rather limited and focuses on the identification of rare variants or the association of sequence 
variants in affected families and patient populations 11-14, 16, 18 as well as on whole genome 
scans.29 Previously, we showed that a mutation in the monocarboxylate transporter 
SLC16A12 causes juvenile cataract, likely via disturbance of solute homeostasis.6  As 
maintenance of homeostasis within the aging lens is likely to be essential 8 this transporter is 
a prime candidate for age-related cataract. The data presented here support this hypothesis. 
First, a point mutation and an SNP within the 5’UTR was found in a 79 year old female with 
age-related cataract.  Second, in vitro and in vivo experiments provide evidence that these 
sequences affect expression of SLC16A12 by modulating translational efficiency. Third, the 
SNP within the 5’UTR is likely associated with age-related cataract within a Swiss 
population.   
The c.-17T>G alteration in the patient with ARC was unique among our patient cohort 
(n=484) and was also absent in our control population (n=180), suggesting that it is a 
mutation rather than an SNP. Supportively, no sequence variation at position c.-17 of 
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SLC16A12 has been reported in available DNA sequence databases to date. The second 
alteration found in cis in the age-related patient is an annotated and only exonic SNP 
rs3740030 (c.-42A>G). Its allele frequency is population dependent. In contrast to a 
Caucasian population of European descent where the minor allele is relatively seldom (8.4 
%), its frequency is higher in a Han Chinese population (27.4 %) (HapMap, January 2010).  
It would be intriguing to investigate whether this is related to the incidence rate of cataract in 
Chinese population.30 Based on our data in a Swiss population, the minor G-allele is more 
frequent in ARC patients compared to the control group. This increased frequency translates 
into an increased risk of approximately 2.2 fold and renders SNP rs3740030 a potential 
modifier in the development of age-related cataract. Numerous examples from genome wide 
association studies (GWAS) demonstrate a population specific effect. Age-related cataract is 
no exception: for example, variants of glutathione-S-transferase have been investigated in 
various ethnically different cataract patient populations with varying results. While no 
association was found in an Italian population 17, the opposite was true for an Estonian 11 and 
Turkish 10 population.  The SNP in SLC16A12 studied here may underlie similar conditions 
since the frequency in the Swiss control population is lower compared to that reported by 
HapMap.  Also, in preliminary studies we were not able to verify the association in a British 
control population.   
Based on the location of the opacity within the lens, one distinguishes between nuclear (the 
most frequent form), cortical, posterior subcapsular and mixed type of cataract.31 Some of the 
risk factors were reported to associate specifically with one of the subtypes of ARC 10, 11, 13 
while association of the N-acetyltransferase 2 isoform “slow” acetylator 12 as well as of 
kinesin light chain KCL1 sequence variants 32 were not. As we did not differentiate between 
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subtypes, the association of SNP rs3740030 in SLC16A12 could account for all ARC but we 
cannot exclude that the increased risk would also be subtype specific.   
The underlying molecular basis for ARC can be explained by altered expression levels of 
SLC16A12. Luciferase activity increases from the common T-allele to the minor G-allele to 
the patient haplotype (G-allele and mutation) thus offering an explanation for predisposing 
and manifestation of the disease. Most likely the pathogenic mechanism acts post-
transcriptionally since equal amounts of the SNP allele-specific SLC16A12 transcripts were 
found and 5’UTR regions are known to harbor control elements that regulate translation.  
This regulation may occur via RNA folding, upstream open reading frames (uORFs), 
differential splicing and/or specific sequence elements. We found no evidence for the latter.  
In contrast, the RNA folding models demonstrated visible, allele-specific differences, with a 
most drastic change for the patient allele. These structural changes correlate with changes in 
luciferase reporter activity. Most likely not a single mechanism is responsible for the 
observed effects. In addition, or complementary to RNA folding, upstream open reading 
frames (uORFs) may be involved. Alterations in uORFs of other genes (TPO, HTR3A, 
BRAC1, TGFß3) were reported to cause various diseases by enhancing gene expression 
through elevating the level of translation.22, 33  The SLC16A12 5’UTR contains four uORFs, 
of which one, that is not in frame with SLC16A12, harbors both sequence alterations 
discussed here. As this uORF expands into the coding frame it may have an inhibitory effect 
on guiding ribosomes beyond the initiation ATG codon. 34-43  The additional feature that the 
SNP G-allele changes the coding frame of that uORF slightly (p.L21W) could also influence 
translational. 
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Differential splicing of the 5’UTR may also explain the allele-specific effects. Examples 
have been reported for the TFII-I transcription factor 44 and for the estrogen receptor beta 
gene.45  For the SNP rs3740030, action of splice factor SRp40, which is predicted to bind 
exclusively to transcripts generated from the minor G-allele, may cause the observed allele-
specific 5’UTR sequence heterogeneity. Furthermore, the skipping of exon 2 causes 
shortening of the 5’UTR and elimination of another uORF, thereby increasing the likelihood 
of influencing translational regulation. Taken together, at least three different mechanisms 
may apply, singly or in concerted action, to explain altered translational efficiency associated 
with the SNP and the mutation within the 5’UTR.   
The knowledge of the exact function of the monocarboxylate transporter SLC16A12 
requires identification of its substrate(s), which is currently under investigation. 
Nevertheless, the facts that an SLC16A12 nonsense mutation leads to juvenile cataract 6 
and that nucleotide changes in the 5’UTR associate with age-related cataract demonstrate 
its importance. As the adult lens structure demands a well functioning transport system 
for metabolites to supply nutrients and remove waste products, 8 the solute carrier 
SLC16A12 may have an important function for that activity. Complete removal of the 
transporter leads to congential cataract and renal glucosuria. 6 In contrast, alterations in 
the amount of the transporter as described here may lead to imbalanced solute 
homeostasis, which over time leads to age-related cataracts.  Due to the expression 
pattern in other tissues than the lens it seems feasible that other organs could experience 
such consequences.  The condition of renal glucosuria is a prime candidate since a 
premature termination codon mutation in SLC16A12 led to this condition 6, but other, not 
yet described physiological conditions could also manifest.  
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We have provided first examples on SLC16A12 5’UTR alterations to be involved in the 
manifestation and pre-disposition of age-related cataract by modifying translational 
efficiency. Physiological consequences are likely to challenge tissue homeostasis and 
transform a healthy lens into a state of diseased.   
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Figure Legend 
 
Fig. 1. Chromatogram showing genomic DNA of 5’UTR section from control individual and 
age-related cataract patient. Nucleotides of the immediate surroundings of SNP rs3740030 
(c.-42) and the mutation (c.-17) are given. K = T and G; R = A and G.   
 
Fig. 2. Quantitative sequencing analysis. (A) Cartoon of exons (ex) 3, 4 and 5 of SLC16A12. 
Exon 3 contains coding region beginning with ATG (light box) and 5’UTR (hatched box) 
containing SNP rs3740030. Genomic DNA (gDNA) and transcript representing cDNA were 
obtained from vascular smooth muscle cells of individual heterozygous for SNP rs3740030 
(c.-42T/G).  RT-PCR primers are indicated with thin arrows in exon 3 and exon 5. Locations 
of primers for genomic DNA amplification are indicated with fat arrows in intronic regions 
flanking exon 3. (B) Quantitative analysis expressed as relative amount of T-allele containing 
transcripts, given in percent, for genomic DNA (gDNA) and mRNA (cDNA). Arrow bars are 
confidence intervals of eight technical replicas.      
 
Fig. 3. Luciferase reporter activity.  (A) Schematic representation of cloned constructs. T-
allele (c.-42T) and G-allele (c.-42G) contain 122 bp of SLC16A12 5’UTR; Patient construct 
contains c.-42G and c.-17G. (B) Relative luciferase activity.  Values obtained for the T-allele 
were set to 1, to which other values were normalized. Displayed are the means (numerically) 
and confidence intervals (graphically) of three technical replicas. Results are from two 
independent experiments. The presence of the G-allele alone shows 1.4-fold and the presence 
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of the G-allele in combination with the mutation (patient) shows a 2.3-fold elevated 
luciferase expression level. 
 
Fig. 4. Predicted SLC16A12 RNA foldings. T-allele and G-allele refer to the SNP rs3740030 
(c.-42T/G). Patient has sequences c.-42G; c.-17G. The top panels (A to C) display RNA 
foldings for the entire SLC16A12 transcript. Differences in mRNA structure are highlighted 
(box). The 5’-end is marked (5’). Dotted line indicates the 5’UTR. Positions c.-42G (U) and 
c.-17G are indicated by arrows. The bottom panels (D to F) depict predicted RNA foldings 
for 5’UTR sequences only.  
 
 
 
Fig. 5. Prediction of splice factor binding site for SLC16A12 5’UTR.  ESE-finder predictions 
were applied to cDNA from T- and G-alleles of SNP rs3740030. Factor SC35 binds to 
independent of the allele sequence.  In contrast, the binding of splice factor SRp40 is 
predicted only for the G-allele sequence. At the position of c.-17 no splice factor binding 
sites are recognized, independent of the nucleotide substitution G>A.   
 
Fig. 6  SLC16A12 transcript analysis by RT-PCR.  Top panel shows schematic representation 
of exons 1 through 5 (size not to scale). Position of SNP rs3740030 and ATG initiation 
codon as well as 5’UTR and coding regions are indicated above the exons.  Primer 
combinations (I, II, III) and their respective sizes (bp) are shown. Bottom panel shows 
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electrophoretically separated RT-PCR products from homozygous T/T (1-4) and 
heterozygous G/T (5-8) donors of vascular smooth muscle cells.   
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Tables 
Table 1.  Primer characteristics.   
Primer name Sequence (5' to 3') Purpose
intronic primers 3F gtctgccccagtctagtattca genomic DNA sequencing
intronic primers 3R cggaaatacacacacaccaca genomic DNA sequencing
CL forward ATGCaagcttGCCAGGTAGCGTTCTATGCC cloning
CL reverse CGGAAATACACACACACCACA cloning
SLC16A12RT_ex1_2f cggtggctcagATACAGGAT RT-PCR
SLC16A12RT_ex4r aaacagccagccacaatcat   RT-PCR
RTPRC_2F GTGTGACCATGCTCTGTGct RT-PCR
RTPRC_4R AAGACAAAGCCCCCAAGAAT RT-PCR
RTPCR_3F caggaagtcactggacagca RT-PCR
RTPCR_5R gcatgattcccacttgacag RT-PCR
cSLC16A12_1F CCCTCTTCCCTCTCCCTGA RT-PCR
cSLC16A12_3R TGTGCAGATGGTAACAAGGAAAC RT-PCR
SLC16A12RTqex2f TTAGCCTCCCAAAGTGATGG RT-PCR
SLC16A12RTqex4r CGTTTGTGCGTAATCCTGAG RT-PCR
 
Table 2. Genotype and allele frequencies of SNP rs3740030. Genotype lists number of 
individuals. Allele frequencies are given in percent.   
TT TG GG total T G total T (%) G (%)
Control 175 14 1 190 364 16 380 95.79 4.21
Juvenile 116 18 0 134 250 18 268 93.28 6.72
Age-related 291 57 2 350 639 61 700 91.29 8.71
genotype alleles
 
Table 3. Association of SNP rs3740030 with cataract.  
odds ratio p Chi 2 odds ratio p Chi 2
Juvenile 1.638 0.8196 3.2736 0.158341 1.99 1.8103 0.8774 3.7352 0.104862 2.63
Age-related 2.1718 1.2339 3.8225 0.006001 7.55 2.3654 1.3021 4.297 0.003836 8.36
CI CI 
allele genotype
  
Odds ratio, confidence interval (CI), p-value and Chi square are listed. Statistical significance 
is reached if odds ratio and CI are >1, p<0.05 and Chi-square > 3.84. 190 control individuals 
(control), 134 patients with juvenile cataract and 350 with age-related cataract were analyzed. 
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